November 25, 2025
By Lionel M. Lavenue; Alvin (Keyi) Xu; Chuanwen Zhou, Ph.D.; Guanshi Li, P.E.; Caitlin T. Coverstone

Patent infringement litigation varies significantly across jurisdictions--especially between China and the United States. For multinational companies, legal professionals, and inventors seeking to protect their intellectual property, understanding these differences is critical.
Recently, a client from China asked for the preparation of a new lawsuit, and when we provided the draft complaint for the new lawsuit, the legal team in China asked why the draft complaint contained only limited details of the infringement – essentially, only good faith allegations. The legal team in China was surprised that such a “barebones” complaint was sufficient, noting that it did not include detailed infringement mappings, with presumptive rebuttals of both non-infringement and even potential invalidity positions. The legal team in China was well versed in Chinese patent law, and Chinese patent litigation, but it had never litigated before in the U.S. We provided some explanation of the differences in the two systems, and this short article resulted.
In China, initiating a patent infringement lawsuit requires plaintiffs to present a comprehensive and specific infringement contention at the very beginning of the case. Plaintiffs are expected to submit, with the initial complaint:
This rigorous requirement is a direct result of China's lack of a formal discovery process. Because parties cannot compel production of documents or testimony from their opponent, courts rely heavily on the initial filings to determine whether the case has merit and should proceed.
In patent infringement litigation in China, as in most civil cases, the burden of proof generally rests with the plaintiff. This principle is affirmed in Article 2 of the Chinese Supreme Court’s Interpretation on the Rules of Evidence in Intellectual Property Litigations. Plaintiffs must present compelling evidence to support their claims from the outset, which shapes the way cases are prepared and filed in Chinese courts. As such, throughout the subsequent trial proceedings, the plaintiff typically independently collects and prepares all evidence required to prove infringement and damages.2
In specific cases, such as cases involving new product manufacturing methods, the court may shift the burden of proof to the defendant once the plaintiff makes a sufficiently persuasive prima facie showing. Even so, plaintiffs in a Chinese court are strongly incentivized to assemble robust and comprehensive evidence at the outset, as there is limited opportunity for further evidence gathering once the case is underway.3
The U.S. system takes a different approach to pleading standard, based primarily on the availability of discovery. And, in the U.S., the threshold for the pleading stage in patent infringement cases is relatively low, compared to the threshold of Chinese patent cases.
In the U.S., plaintiffs are not expected to produce evidence at the outset. Instead, the pleading standards set by the U.S. Supreme Court in Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (2007) and Ashcroft v. Iqbal, 556 U.S. 662 (2009) only requires the complaint to state a “plausible” claim. In patent cases, this means that the complaint must contain “factual allegations that, when taken as true, articulate why it is plausible that the accused product infringes the patent claim. AlexSam, Inc. v. Aetna, Inc., 119 F.4th 37, 35 (Fed. Cir. 2024). Depending on the complexity/materiality of an element to practicing the asserted claim, the complaint can even omit some claim elements. Id.
This comparatively lower threshold, as contrasted with the system in China, is balanced by the U.S. legal system’s broad discovery process, which allows parties to use the discovery to obtain and exchange evidence before finalizing their infringement or invalidity contentions. F.R.C.P. Rule 26. Discovery enables both sides to request documents, depose witnesses, and gather information that may be critical to proving—or disproving—infringement. The plaintiffs can also amend pleadings in light of findings from the discovery with leave of court. Because discovery plays such a central role, U.S. complaints often begin with less detail, with the expectation that critical evidence will emerge during litigation.
These procedural differences carry significant strategic consequences:
For accused infringers, this difference in systems means that early defenses in China focus on attacking the sufficiency of the initial evidence, but U.S. defendants cannot generally ask for immediate case resolution, as the discovery process must occur first.
Effective global patent enforcement requires tailoring litigation strategy to each jurisdiction’s procedural framework. China’s front-loaded system demands comprehensive infringement evidence at filing, while the U.S. system permits cases to proceed with minimal initial detail—relying on discovery to develop the factual record.
For companies operating internationally, recognizing and adapting to these differences is essential to protecting intellectual property and managing litigation risk.
[1] See, for example, Appendix 2: infringement mapping, page 397 of The Template of Pleadings, The Supreme People's Court of the People's Republic of China, https://www.court.gov.cn/fabu/xiangqing/468671.html, https://www.court.gov.cn/upload/file/2025/06/22/17/43/202506221742_01.pdf;
[2] See, for example, http://gongbao.court.gov.cn/Details/517a2b30803250a76e2c6116325328.html?;
[3] See, for example, Article 66 of the Chinese Patent Law, addressing this burden-shifting mechanism for new product manufacturing methods; https://www.cnipa.gov.cn/art/2020/11/23/art_97_155167.html; and, also see, for example, Article 3 of the Supreme Court's Interpretation, stipulating that, under certain circumstances, the burden of proof may also shift in cases concerning manufacturing methods of existing products, http://gongbao.court.gov.cn/Details/517a2b30803250a76e2c6116325328.html.
Copyright © Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.